Cargando…
恩沙替尼治疗EML4-ALK/TP53共突变肺鳞癌1例并文献复习
Lung squamous cell carcinoma (LSCC) accounts for approximately 30% of non-small cell lung cancer (NSCLC) cases and is the second most common histological type of lung cancer. Anaplastic lymphoma kinase (ALK)-positive NSCLC accounts for only 2%-5% of all NSCLC cases, and is almost exclusively detecte...
Autores principales: | LV, Donglai, XU, Chunwei, WANG, Chong, SANG, Qiuju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987096/ https://www.ncbi.nlm.nih.gov/pubmed/36792084 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.03 |
Ejemplares similares
-
盐酸恩沙替尼胶囊的药理与临床评价
Publicado: (2020) -
厄洛替尼致间质性肺病4例并文献复习
Publicado: (2012) -
芦可替尼治疗慢性中性粒细胞白血病一例报告并文献复习
Publicado: (2018) -
肺上皮-肌上皮癌1例并文献复习
Publicado: (2020) -
厄洛替尼治疗34例肺鳞癌患者的疗效观察
Publicado: (2016)